Naama Aviram

Affiliations: 
Rockefeller University, New York, NY, United States 
Google:
"Naama Aviram"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Aviram N, Shilton AK, Lyn NG, et al. (2024) The Cas10 nuclease activity relieves host dormancy to facilitate spacer acquisition and retention during type III-A CRISPR immunity. Biorxiv : the Preprint Server For Biology
Cohen N, Aviram N, Schuldiner M. (2023) A systematic proximity ligation approach to studying protein-substrate specificity identifies the substrate spectrum of the Ssh1 translocon. The Embo Journal. e113385
Aviram N, Thornal AN, Zeevi D, et al. (2022) Different modes of spacer acquisition by the Staphylococcus epidermidis type III-A CRISPR-Cas system. Nucleic Acids Research. 50: 1661-1672
Dahan N, Bykov YS, Boydston EA, et al. (2022) Peroxisome function relies on organelle-associated mRNA translation. Science Advances. 8: eabk2141
Hansen KG, Aviram N, Laborenz J, et al. (2018) An ER surface retrieval pathway safeguards the import of mitochondrial membrane proteins in yeast. Science (New York, N.Y.). 361: 1118-1122
Aviram N, Schuldiner M. (2017) Targeting and translocation of proteins to the endoplasmic reticulum at a glance. Journal of Cell Science. 130: 4079-4085
Casson J, McKenna M, Haßdenteufel S, et al. (2017) Multiple pathways facilitate the biogenesis of mammalian tail-anchored proteins. Journal of Cell Science
Haßdenteufel S, Sicking M, Schorr S, et al. (2017) hSnd2 protein represents an alternative targeting factor to the endoplasmic reticulum in human cells. Febs Letters
Aviram N, Ast T, Costa EA, et al. (2016) The SND proteins constitute an alternative targeting route to the endoplasmic reticulum. Nature. 540: 134-138
Ast T, Aviram N, Chuartzman SG, et al. (2014) A cytosolic degradation pathway, prERAD, monitors pre-inserted secretory pathway proteins Journal of Cell Science. 127: 3017-3023
See more...